Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial | |
Li, Li; Zhuang, Qingqing; Cao, Zeyi; Yin, Rutie; Zhu, Yaping; Zhu, Lirong; Xie, Xing; Zhang, Youzhong; Wu, Qiang; Zheng, Jianhua | |
2018 | |
卷号 | 15期号:3页码:3646-3652 |
关键词 | epithelial ovarian cancer nedaplatin carboplatin paclitaxel chemotherapy |
ISSN号 | 1792-1074 |
DOI | 10.3892/ol.2018.7761 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6360033 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Li, Li,Zhuang, Qingqing,Cao, Zeyi,et al. Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial[J],2018,15(3):3646-3652. |
APA | Li, Li.,Zhuang, Qingqing.,Cao, Zeyi.,Yin, Rutie.,Zhu, Yaping.,...&Wang, Changyu.(2018).Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial.,15(3),3646-3652. |
MLA | Li, Li,et al."Paclitaxel plus nedaplatin vs. paclitaxel plus carboplatin in women with epithelial ovarian cancer: A multi-center, randomized, open-label, phase III trial".15.3(2018):3646-3652. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论